The lack of expression of estrogen receptor alpha (ERa/ESR1) in type 1 EC was found to be associated with poor differentiation of cancer tissues and poor survival rates of EC patients, respectively [5,6], supporting the hypothesis of a direct involvement of ERa in EC tumorigenesis and progression. Here, ESR1 is linked to cancer.